Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Tricyclic 5alpha-reductase inhibitors designed at Merck & Co.

March 14, 2000

Phase III trial of Anogesic as treatment for anal fissure pain commences

March 13, 2000

In vitro and in vivo studies with specific chymase inhibitor suggest potential in atopic dermatitis

March 6, 2000

Wound-healing gene therapy using NAB2

Feb. 29, 2000

Pfizer presents new urokinase inhibitors for wound healing, etc.

Feb. 28, 2000

Pig small intestine submucosa shows efficacy in wound healing

Feb. 25, 2000

Modified oligonucleotides with staggered PS/PO linkages designed at Isis

Feb. 24, 2000

Switch Biotech files patent applications for wound-healing genes

Feb. 23, 2000

Topical tazarotene effective in congenital ichthyosis

Feb. 18, 2000

Antipsoriatic activity of EGF receptor tyrosine kinase inhibitor SU-5271

Feb. 15, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...